Muscle relaxant may be viable treatment for rare form of diabetes

Muscle relaxant may be viable treatment for rare form of diabetes A commonly prescribed muscle relaxant may be an effective treatment for a rare but devastating form of diabetes, researchers at Washington University School of Medicine in St. Louis report. The drug, dantrolene, prevents the destruction of insulin-producing beta cells both in animal models of Wolfram syndrome and in cell ... Read More »

Only half of patients take their medications as prescribed

Only half of patients take their medications as prescribed Here is what we know: If people take medications prescribed to them, they usually get better. But only about half of all patients prescribed medication take it according to directions. Here is what we don’t know: We don’t know how to get patients to take their medications, despite many studies looking ... Read More »

Novo Nordisk ranks second on the 2014 Access to Medicine Index

Novo Nordisk ranks second on the 2014 Access to Medicine Index Today, it was announced that Novo Nordisk ranks second on the 2014 Access to Medicine Index, climbing four places since the 2012 Index. Novo Nordisk’s ranking is a reflection of the company’s inclusion of access to medicine within its core business, including equitable pricing strategies, local capability building and ... Read More »

Scientists at Houston Methodist may have discovered a new way to repair damaged tissue

Scientists at Houston Methodist may have discovered a new way to repair damaged tissue By transforming human scar cells into blood vessel cells, scientists at Houston Methodist may have discovered a new way to repair damaged tissue. The method, described in an upcoming issue of Circulation, appeared to improve blood flow, oxygenation, and nutrition to areas in need. Cardiovascular scientists ... Read More »

GSK seeks US FDA & European approval for mepolizumab to treat patients with severe eosinophilic asthma

GSK seeks US FDA & European approval for mepolizumab to treat patients with severe eosinophilic asthma GlaxoSmithKline plc has filed regulatory submissions in the USA and Europe for mepolizumab for approval as a maintenance treatment for patients with severe eosinophilic asthma, identified by a blood eosinophil count of at least 150 cells per microlitre at the start of treatment or ... Read More »

NSAIDs prevent colon cancer by inducing death of intestinal stem cells that have mutation

NSAIDs prevent colon cancer by inducing death of intestinal stem cells that have mutation Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) protect against the development of colorectal cancer by inducing cell suicide pathways in intestinal stem cells that carry a certain mutated and dysfunctional gene, according to a new study led by researchers at the University of Pittsburgh Cancer Institute ... Read More »

Lupin Q2 net profit jumps 54 per cent as US, India sales rise

Lupin Q2 net profit jumps 54 per cent as US, India sales rise Generic drugmaker Lupin has reported a 54 per cent jump in second-quarter profit beating analysts estimates, helped by robust sales in its domestic business and the United States, its largest market. Lupin, India’s second-largest drugmaker by market value, posted a net profit of Rs 6.3 billion ($102.7 ... Read More »

Natco Pharma’s US partner gets FDA nod for wakefulness tablets

Natco Pharma’s US partner gets FDA nod for wakefulness tablets NEW DELHI: Natco Pharma’s marketing partner in US, Breckenridge Pharmaceutical Inc, has received a tentative approval from the US health regulator for its generic Armodafinil tablets used for improving wakefulness in adults. Breckenridge Pharmaceutical Inc has received tentative approval from the United States Food and Drug Administration (USFDA) for Armodafinil ... Read More »

BioReliance launches advanced in-vitro ADME and toxicology services designed to improve drug safety and efficacy

BioReliance launches advanced in-vitro ADME and toxicology services designed to improve drug safety and efficacy BioReliance, Sigma-Aldrich Corporation’s biologics and early-development services business under SAFC Commercial, has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services for pharmaceutical, chemical and industrial consumer products to its service offering. The broad set of highly predictive assays use ... Read More »

Pharma patent regime may get stricter, say experts

Pharma patent regime may get stricter, say experts In order to boost dollar inflows in pharma sector and establish stronger IPR regime, govt may affect patent amendments The joint statement issued on September 30 by the US and India to establish an annual high-level Intellectual Property (IP) working group has inevitably led to a debate on whether the governmentwould bow ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com